Abstract:Acute liver failure is a rare hepatic emergent situation that affects primarily young people and has often a catastrophic or even fatal outcome. Definition of acute liver failure has not reached a universal consensus and the interval between the appearance of jaundice and hepatic encephalopathy for the establishment of the acute failure is a matter of debate. Among the wide variety of causes, acetaminophen intoxication in western societies and viral hepatitis in the developing countries rank at the top of the … Show more
“…The most common cause of acute liver failure is viral infections. 29 As liver regeneration begins and spontaneous recovery is likely soon after removing the toxins that cause liver damage, TPE is immensely effective for toxin clearance and for intercepting liver failure and its complications. With…”
Section: Discussionmentioning
confidence: 99%
“…Acute liver failure is a progressive and fatal disease that causes severe conditions such as encephalopathy, coagulopathy, and hypoglycemia. The most common cause of acute liver failure is viral infections 29 . As liver regeneration begins and spontaneous recovery is likely soon after removing the toxins that cause liver damage, TPE is immensely effective for toxin clearance and for intercepting liver failure and its complications.…”
BackgroundThe aim of this study is to characterize the clinical indications, outcomes, and complications of therapeutic plasma exchange (TPE) in pediatric intensive care unit.MethodsA retrospective study was conducted on critically ill patients who received TPE. A dataset of 672 treatments administered to 102 patients was analyzed.ResultsThe most common indication for TPE was COVID‐19‐related clinical conditions, followed by sepsis (24.5%), neurological diseases (9.8%) and renal diseases (6.9%). None of our patients died due to TPE‐related complications, and the most common complication during and after the TPE was hypotension (21.7%).ConclusionAlthough TPE is riskier to provide to critically ill children, our experience indicates that it can be performed relatively safely in critically ill children with appropriate treatment indications. In particular, indications, onset time, number of sessions and other procedures should be standardized for the pediatric age group.
“…The most common cause of acute liver failure is viral infections. 29 As liver regeneration begins and spontaneous recovery is likely soon after removing the toxins that cause liver damage, TPE is immensely effective for toxin clearance and for intercepting liver failure and its complications. With…”
Section: Discussionmentioning
confidence: 99%
“…Acute liver failure is a progressive and fatal disease that causes severe conditions such as encephalopathy, coagulopathy, and hypoglycemia. The most common cause of acute liver failure is viral infections 29 . As liver regeneration begins and spontaneous recovery is likely soon after removing the toxins that cause liver damage, TPE is immensely effective for toxin clearance and for intercepting liver failure and its complications.…”
BackgroundThe aim of this study is to characterize the clinical indications, outcomes, and complications of therapeutic plasma exchange (TPE) in pediatric intensive care unit.MethodsA retrospective study was conducted on critically ill patients who received TPE. A dataset of 672 treatments administered to 102 patients was analyzed.ResultsThe most common indication for TPE was COVID‐19‐related clinical conditions, followed by sepsis (24.5%), neurological diseases (9.8%) and renal diseases (6.9%). None of our patients died due to TPE‐related complications, and the most common complication during and after the TPE was hypotension (21.7%).ConclusionAlthough TPE is riskier to provide to critically ill children, our experience indicates that it can be performed relatively safely in critically ill children with appropriate treatment indications. In particular, indications, onset time, number of sessions and other procedures should be standardized for the pediatric age group.
“…In addition to these complications, liver function plays a crucial role for the outcome of patients treated with ECLS [11]. Acute liver dysfunction and hypoxic liver injury are life-threatening events associated with a mortality rate of up to 80% [12,13]. Some authors tried to identify pre-ECLS factors with prognostic value, e.g., the "Survival after Veno-Arterial Extracorporeal Membrane Oxygenation" (SAVE) score, which may be a tool to predict the survival of patients receiving ECLS for refractory cardiogenic shock [7].…”
Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme levels could serve as prognostic mortality markers for patients with ECLS. The present study is a retrospective single-center cohort study. Adult patients >18 years of age who received ECLS therapy between 2011 and 2018 were included. Bilirubin, glutamic-oxaloacetic transaminase (GOT), and glutamic-pyruvic-transaminase (GPT) serum levels were analyzed at day 5 after the start of the ECLS therapy. The primary endpoint of this study was all-cause in-hospital mortality. A total of 438 patients received ECLS during the observation period. Based on the inclusion criteria, 298 patients were selected for the statistical analysis. The overall mortality rate was 42.6% (n = 127). The area under the curve (AUC) in the receiver operating characteristic curve (ROC) for bilirubin on day 5 was 0.72 (95% confidence interval (CI): 0.66–0.78). Cox regression with multivariable adjustment revealed a significant association between bilirubin on day 5 and mortality, with a hazard ratio (HR) of 2.24 (95% CI: 1.53–3.30). Based on the results of this study, an increase in serum bilirubin on day 5 of ECLS therapy correlates independently with mortality.
“…system in the case of SLI treatment is also recognized in the USA 10 . A review by Dr. Doulberis and his colleagues mentioned that the standard management for SLI indicates transferring the patient to a core center prior to HE development to prepare for liver transplantation 11 . As liver transplantation is the only established curative treatment for ALF 4,11,12 , this is an important procedure for improved prognosis; however, there is currently a shortage of liver donors.…”
mentioning
confidence: 99%
“…A review by Dr. Doulberis and his colleagues mentioned that the standard management for SLI indicates transferring the patient to a core center prior to HE development to prepare for liver transplantation 11 . As liver transplantation is the only established curative treatment for ALF 4,11,12 , this is an important procedure for improved prognosis; however, there is currently a shortage of liver donors. Although introduction of presumed consent increases the numbers [13][14][15] , establishing an adequate organ supply based on appropriate indications for liver transplantation is crucial.…”
In 2004, we implemented a referral system for patients with acute liver injury (ALI) based on an established formula that estimates the risk of progression to acute live failure (ALF); however, the benefits of the system for patients with severe acute liver injury (SLI) remain unclear. We have evaluated the clinical significance of the referral system for SLI patients. Patients with ALI/SLI who were consecutively and prospectively listed on the system between 2004 and 2018 were analyzed. Of the 371 ALI/SLI/ALF patients on the system, 124 satisfied the criteria for SLI; 34 of these 124 progressed to SLI after registration. Multivariate analysis using age, sex, AST, ALT, creatinine, total bilirubin, prothrombin, presence of hepatic encephalopathy (HE), and SLI at registration revealed that HE was associated with high mortality. Among the 23 patients who developed HE, five who progressed to SLI after registration showed an increased time to HE development compared with patients who had SLI at the time of registration. However, there was no significant difference in survival time after HE development. We concluded that early identification of SLI patients using the referral system increased the time from SLI diagnosis to HE development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.